The total number of records retrieved from this search are 38. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1975	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1976	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1977	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1978	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1979	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1980	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.0005 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1981	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result90% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1982	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result97% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1983	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result97% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1984	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result80% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1985	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result90% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1986	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.005 MOI	In-vitro result98% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1987	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result70% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1988	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result80% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1989	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result90% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1990	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result45% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1991	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result50% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1992	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.05 MOI	In-vitro result90% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1993	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result60% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1994	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result70% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1995	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result70% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1996	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result30% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1997	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result30% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1998	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.5 MOI	In-vitro result50% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_1999	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result45% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2000	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result60% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2001	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result45% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2002	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result18% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2003	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result20% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2004	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration2.5 MOI	In-vitro result58% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2005	Virus nameNewcastle disease virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result38% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2006	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result42% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2007	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result42% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2008	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result10% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2009	Virus nameReovirus	Virus strainReovirus T3D	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationReovirus in combination with parovirus	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result12% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_2010	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationParovirus in combination with NDV	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman glioma cell line	Cell lineU373	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result52% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus alone and in combination enhance apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21607667
IDOV_5614	Virus nameNewcastle disease virus	Virus strainNDV-MK107	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman glioblastoma cell line	Cell lineU373MG	Concentration of cell line80% confluency	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration765 pfu	In-vitro result50% of cancer cell death occurs	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis by virus infection	Immunogenic effectInduction of IFN-Gamma production	Clinical trialNA	PMIDUS7470426
IDOV_5834	Virus nameNewcastle disease virus	Virus strainNDV-PPMK107	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman glioblastoma cell line	Cell lineU373MG	Concentration of cell line80% confluency	In-vitro toxicityNA	AssayNA	In-vitro virus concentration765 pfu	In-vitro result50% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMIDUS8105578